Genomic Uracil Homeostasis During Normal B Cell Maturation and Loss of This Balance During B Cell Cancer Development

Overview

Journal Mol Cell Biol

Specialty Cell Biology

Date 2014 Aug 27

PMID 25154417

Citations 17

Authors

Sophia Shalhout

Dania Haddad

Angela Sosin

Thomas C Holland

Ayad Al-Katib

Alberto Martin

Ashok S Bhagwat

Affiliations

Soon will be listed here.

Abstract

Activation-induced deaminase (AID) converts DNA cytosines to uracils in immunoglobulin genes, creating antibody diversification. It also causes mutations and translocations that promote cancer. We examined the interplay between uracil creation by AID and its removal by UNG2 glycosylase in splenocytes undergoing maturation and in B cell cancers. The genomic uracil levels remain unchanged in normal stimulated B cells, demonstrating a balance between uracil generation and removal. In stimulated UNG(-/-) cells, uracil levels increase by 11- to 60-fold during the first 3 days. In wild-type B cells, UNG2 gene expression and enzymatic activity rise and fall with AID levels, suggesting that UNG2 expression is coordinated with uracil creation by AID. Remarkably, a murine lymphoma cell line, several human B cell cancer lines, and human B cell tumors expressing AID at high levels have genomic uracils comparable to those seen with stimulated UNG(-/-)splenocytes. However, cancer cells express UNG2 gene at levels similar to or higher than those seen with peripheral B cells and have nuclear uracil excision activity comparable to that seen with stimulated wild-type B cells. We propose that more uracils are created during B cell cancer development than are removed from the genome but that the uracil creation/excision balance is restored during establishment of cell lines, fixing the genomic uracil load at high levels.

Citing Articles

A Germinal Center Checkpoint of AIRE in B Cells Limits Antibody Diversification.

Zhou J, Huang B, Pei B, Sun G, Pawlitz M, Zhang W bioRxiv. 2024; .

PMID: 38260362 PMC: 10802573. DOI: 10.1101/2024.01.10.574926.

RPA guides UNG to uracil in ssDNA to facilitate antibody class switching and repair of mutagenic uracil at the replication fork.

Hayran A, Liabakk N, Aas P, Kusnierczyk A, Vagbo C, Sarno A Nucleic Acids Res. 2023; 52(2):784-800.

PMID: 38000394 PMC: 10810282. DOI: 10.1093/nar/gkad1115.

Divergent structures of Mammalian and gammaherpesvirus uracil DNA glycosylases confer distinct DNA binding and substrate activity.

Mu Y, Zelazowska M, Chen Z, Plummer J, Dong Q, Krug L DNA Repair (Amst). 2023; 128:103515.

PMID: 37315375 PMC: 10441670. DOI: 10.1016/j.dnarep.2023.103515.

Metabolomics: A New Era in the Diagnosis or Prognosis of B-Cell Non-Hodgkin's Lymphoma.

Alfaifi A, Refai M, Alsaadi M, Bahashwan S, Malhan H, Al-Kahiry W Diagnostics (Basel). 2023; 13(5).

PMID: 36900005 PMC: 10000528. DOI: 10.3390/diagnostics13050861.

Intrinsic Strand-Incision Activity of Human UNG: Implications for Nick Generation in Immunoglobulin Gene Diversification.

Alexeeva M, Moen M, Xu X, Rasmussen A, Leiros I, Kirpekar F Front Immunol. 2022; 12:762032.

PMID: 35003074 PMC: 8730318. DOI: 10.3389/fimmu.2021.762032.

References

Mashiyama S, Hansen C, Roitman E, Sarmiento S, Leklem J, Shultz T . An assay for uracil in human DNA at baseline: effect of marginal vitamin B6 deficiency. Anal Biochem. 2007; 372(1):21-31. PMC: 2175266. DOI: 10.1016/j.ab.2007.08.034. View

Chaudhuri J, Tian M, Khuong C, Chua K, Pinaud E, Alt F . Transcription-targeted DNA deamination by the AID antibody diversification enzyme. Nature. 2003; 422(6933):726-30. DOI: 10.1038/nature01574. View

Chiarle R, Zhang Y, Frock R, Lewis S, Molinie B, Ho Y . Genome-wide translocation sequencing reveals mechanisms of chromosome breaks and rearrangements in B cells. Cell. 2011; 147(1):107-19. PMC: 3186939. DOI: 10.1016/j.cell.2011.07.049. View

Storb U . Why does somatic hypermutation by AID require transcription of its target genes?. Adv Immunol. 2014; 122:253-77. DOI: 10.1016/B978-0-12-800267-4.00007-9. View

Yamane A, Resch W, Kuo N, Kuchen S, Li Z, Sun H . Deep-sequencing identification of the genomic targets of the cytidine deaminase AID and its cofactor RPA in B lymphocytes. Nat Immunol. 2010; 12(1):62-9. PMC: 3005028. DOI: 10.1038/ni.1964. View

Di Noia J, Neuberger M . Molecular mechanisms of antibody somatic hypermutation. Annu Rev Biochem. 2007; 76:1-22. DOI: 10.1146/annurev.biochem.76.061705.090740. View

Okazaki I, Hiai H, Kakazu N, Yamada S, Muramatsu M, Kinoshita K . Constitutive expression of AID leads to tumorigenesis. J Exp Med. 2003; 197(9):1173-81. PMC: 2193972. DOI: 10.1084/jem.20030275. View

Li G, Zan H, Xu Z, Casali P . Epigenetics of the antibody response. Trends Immunol. 2013; 34(9):460-70. PMC: 3744588. DOI: 10.1016/j.it.2013.03.006. View

Winter D, Phung Q, Umar A, Baker S, Tarone R, Tanaka K . Altered spectra of hypermutation in antibodies from mice deficient for the DNA mismatch repair protein PMS2. Proc Natl Acad Sci U S A. 1998; 95(12):6953-8. PMC: 22699. DOI: 10.1073/pnas.95.12.6953. View

10.

Roberts S, Lawrence M, Klimczak L, Grimm S, Fargo D, Stojanov P . An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat Genet. 2013; 45(9):970-6. PMC: 3789062. DOI: 10.1038/ng.2702. View

11.

Zhang W, Bardwell P, Woo C, Poltoratsky V, Scharff M, Martin A . Clonal instability of V region hypermutation in the Ramos Burkitt's lymphoma cell line. Int Immunol. 2001; 13(9):1175-84. DOI: 10.1093/intimm/13.9.1175. View

12.

An Q, Robins P, Lindahl T, Barnes D . C --> T mutagenesis and gamma-radiation sensitivity due to deficiency in the Smug1 and Ung DNA glycosylases. EMBO J. 2005; 24(12):2205-13. PMC: 1150883. DOI: 10.1038/sj.emboj.7600689. View

13.

Dickerson S, Market E, Besmer E, Papavasiliou F . AID mediates hypermutation by deaminating single stranded DNA. J Exp Med. 2003; 197(10):1291-6. PMC: 2193777. DOI: 10.1084/jem.20030481. View

14.

Ramiro A, Jankovic M, Eisenreich T, Difilippantonio S, Chen-Kiang S, Muramatsu M . AID is required for c-myc/IgH chromosome translocations in vivo. Cell. 2004; 118(4):431-8. DOI: 10.1016/j.cell.2004.08.006. View

15.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

16.

Roche B, Claes A, Rougeon F . Deoxyuridine triphosphate incorporation during somatic hypermutation of mouse VkOx genes after immunization with phenyloxazolone. J Immunol. 2010; 185(8):4777-82. DOI: 10.4049/jimmunol.1001459. View

17.

Shen H, Peters A, Baron B, Zhu X, STORB U . Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science. 1998; 280(5370):1750-2. DOI: 10.1126/science.280.5370.1750. View

18.

Maul R, Saribasak H, Martomo S, McClure R, Yang W, Vaisman A . Uracil residues dependent on the deaminase AID in immunoglobulin gene variable and switch regions. Nat Immunol. 2010; 12(1):70-6. PMC: 3653439. DOI: 10.1038/ni.1970. View

19.

Andersen S, Ericsson M, Dai H, Pena-Diaz J, Slupphaug G, Nilsen H . Monoclonal B-cell hyperplasia and leukocyte imbalance precede development of B-cell malignancies in uracil-DNA glycosylase deficient mice. DNA Repair (Amst). 2005; 4(12):1432-41. DOI: 10.1016/j.dnarep.2005.08.004. View

20.

Nik-Zainal S, Alexandrov L, Wedge D, Van Loo P, Greenman C, Raine K . Mutational processes molding the genomes of 21 breast cancers. Cell. 2012; 149(5):979-93. PMC: 3414841. DOI: 10.1016/j.cell.2012.04.024. View